Hidradenitis Suppurativa (HS) Completed Phase 2 Trials for Bimekizumab (DB12917)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03248531A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.Treatment